MYRTLE BEACH, SC and QUEBEC CITY, April 2, 2019 /CNW Telbec/ - TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has appointed Sara Elford to the Company's board of directors and further announced the resignation of Douglas Dieter.
Ms. Elford enjoyed a long and successful career in Canadian capital markets. From 1998 to 2015, she was a Sell-Side Equity Research Analyst covering Sustainability and Special Situations at Canaccord Genuity, where she was consistently ranked by Brendan Wood International and won numerous StarMine awards for stock picking. Previously, she held positions with Brink, Hudson & Lefevre and CIBC Wood Gundy in Vancouver and started her career in New York at Kidder Peabody & Co as an Investment Banking Analyst. Ms. Elford now applies her skills and experience in the capacity of investor, strategic advisor and corporate director. She currently sits on the boards of BioSyent Inc., Carmanah Technologies Corporation and Hydrogenics Corporation, and was a past director of Pure Technologies. She is a CFA Charterholder and is a graduate of Bishop's University with a Finance Major and Economics Minor.
"We are pleased to welcome Sara to our board of directors," stated Dr. Linda Rosenstock, Chairperson of the board of TSO3. "Her reputation in capital markets, intimate knowledge of the Company and long-standing relationships with many of our shareholders will bring additional value to TSO3's independent board of directors and to our management team."
The Company also announced that Douglas Dieter has tendered his resignation as a member of the board of directors. The board wishes to thank him for his contribution.
About TSO3
Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. For more information about TSO3, visit the Company's website at www.tso3.com.
SOURCE TSO3 Inc.
Company Contacts: R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: [email protected]; Glen Kayll, CFO, Tel: 418 651-0003, Email: [email protected]; Investor Relations: Danielle Ste-Marie, Ste-Marie Strategy & Communications Inc., Tel: 1-514-465-6701, Email: [email protected]
Share this article